DDX6 undergoes phase separation to modulate metabolic plasticity and drug resistance in AML
Ontology highlight
ABSTRACT: DDX6 is a member of the DEAD-box helicase and it is highly expressed in acute myeloid leukemia (AML). The Knockout (KO) of DDX6 in AML cells significantly suppressed their growth, reduced their mitochondrial oxidative phosphorylation (OXPHOS) in vitro, and substantially delayed leukemogenesis in vivo. To delineate the molecular mechanism through which DDX6 exerts its biological functions in AML, we conducted transcriptome-wide RNA sequencing with Mono-mac-6 AML cells following DDX6 KO.
ORGANISM(S): Homo sapiens
PROVIDER: GSE277986 | GEO | 2025/07/27
REPOSITORIES: GEO
ACCESS DATA